UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Cellebrite
CLBT
$3.99B
| $4.25M | ﹤0.01% |
355,317
+145,144
| +69% | +$1.62M |
|
|
RERE
3027
ATRenew
RERE
$1.01B
| $4.24M | ﹤0.01% |
1,791,049
+95,242
| +6% | +$209K |
|
3028
Liberty Media Series A
FWONA
$23.6B
| $4.24M | ﹤0.01% |
65,946
-80,024
| -55% | -$5.09M |
|
3029
Madison Square Garden
MSGS
$9.39B
| $4.23M | ﹤0.01% |
22,508
+4,486
| +25% | +$832K |
|
|
SCHR
3030
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $4.23M | ﹤0.01% |
173,606
+30,808
| +22% | +$746K |
|
3031
Wyndham Hotels & Resorts
WH
$5.48B
| $4.23M | ﹤0.01% |
57,198
+19,886
| +53% | +$1.43M |
|
3032
PUT
CME Group
CME
$94.8B
| $4.23M | ﹤0.01% |
21,500
-113,000
| -84% | -$23.3M |
|
3033
PUT
PPG Industries
PPG
$26.6B
| $4.22M | ﹤0.01% |
33,500
+10,000
| +43% | +$1.32M |
|
3034
Adient
ADNT
$1.5B
| $4.2M | ﹤0.01% |
170,073
-70,023
| -29% | -$1.99M |
|
3035
Landstar System
LSTR
$6.21B
| $4.2M | ﹤0.01% |
22,755
-64,971
| -74% | -$11.7M |
|
3036
Applied Industrial Technologies
AIT
$13.3B
| $4.2M | ﹤0.01% |
21,636
-28,399
| -57% | -$5.42M |
|
3037
iShares MSCI Emerging Markets Asia ETF
EEMA
$860M
| $4.2M | ﹤0.01% |
57,907
+3,710
| +7% | +$261K |
|
3038
CorVel
CRVL
$3.19B
| $4.19M | ﹤0.01% |
49,485
-2,241
| -4% | -$185K |
|
3039
Brookfield Renewable
BEP
$9.96B
| $4.19M | ﹤0.01% |
169,261
+110,875
| +190% | +$2.76M |
|
3040
CALL
Universal Display
OLED
$4.19B
| $4.18M | ﹤0.01% |
19,900
| – | – |
|
3041
PTC Therapeutics
PTCT
$6.12B
| $4.18M | ﹤0.01% |
136,761
-88,699
| -39% | -$2.87M |
|
3042
ADMA Biologics
ADMA
$2.22B
| $4.18M | ﹤0.01% |
373,937
-191,494
| -34% | -$1.61M |
|
3043
Alight
ALIT
$407M
| $4.18M | ﹤0.01% |
28,310
+2,361
| +9% | +$393K |
|
3044
CALL
Pan American Silver
PAAS
$21.6B
| $4.17M | ﹤0.01% |
+210,000
| New | +$4.14M |
|
3045
VanEck Biotech ETF
BBH
$422M
| $4.16M | ﹤0.01% |
24,694
-604
| -2% | -$98.8K |
|
3046
CALL
Bentley Systems
BSY
$10.6B
| $4.15M | ﹤0.01% |
+84,000
| New | +$4.36M |
|
3047
ICF International
ICFI
$1.72B
| $4.15M | ﹤0.01% |
27,926
-14,782
| -35% | -$2.14M |
|
3048
Columbia Sportswear
COLM
$2.94B
| $4.14M | ﹤0.01% |
52,361
+38,425
| +276% | +$3.11M |
|
3049
iShares MSCI Europe Financials ETF
EUFN
$4.3B
| $4.14M | ﹤0.01% |
184,954
-32,921
| -15% | -$756K |
|
3050
National Health Investors
NHI
$3.65B
| $4.14M | ﹤0.01% |
61,059
-20,608
| -25% | -$1.32M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.